Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence Stephanie A. Navarro SilveraThomas E. Rohan Review 12 September 2007 Pages: 397 - 409
Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC) Ander UrruticoecheaMonica ArnedosIan E. Smith Review 13 September 2007 Pages: 411 - 416
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases Dmitry A. TurbinSamuel LeungDavid G. Huntsman Preclinical Study 03 October 2007 Pages: 417 - 426
The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome Andrew R. GreenClaire BurneyEleni Stylianou Preclinical Study 28 September 2007 Pages: 427 - 437
Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria Lorenza PutignaniSalvatore RaffaPaola Grammatico Preclinical Study 26 September 2007 Pages: 439 - 452
Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers Ankit BharatNicholas BenshoffT. Mohanakumar Preclinical Study 15 September 2007 Pages: 453 - 463
Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer Yutaka YamamotoMutsuko IbusukiHirotaka Iwase Preclinical Study 06 September 2007 Pages: 465 - 475
Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables Woo Chul NohYang Hee KimNam-Sun Paik Preclinical Study 06 September 2007 Pages: 477 - 483
Favourable long-term results after surgical removal of lung metastases of breast cancer Masataka YoshimotoKeiichiro TadaKen Nakagawa Preclinical study 27 September 2007 Pages: 485 - 491
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells Jennifer L. GilmoreJeffrey A. ScottJohn Foley Preclinical Study 20 September 2007 Pages: 493 - 505
Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines Oliver TreeckIngolf Juhasz-BoessOlaf Ortmann Preclinical Study 18 September 2007 Pages: 507 - 520
Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue Vanesa MartinezSusan KennedyLorraine O’Driscoll Epidemiology 27 September 2007 Pages: 521 - 530
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival Masakazu ToiSeigo Nakamurafor Japan Breast Cancer Research Group (JBCRG) Clinical Trial 19 September 2007 Pages: 531 - 539
Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors Hakan HarputluogluOmer DizdarKadri Altundag Letter to the editor 13 September 2007 Pages: 541 - 541
Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population Patricio González-HormazábalVíctor G. CastroLilian Jara Led to the Editor 18 September 2007 Pages: 543 - 545
